# Correction: Raha et al. Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α. Cells 2023, 12, 2791

**Authors:** Sumita Raha, Debashis Dutta, Ramesh K. Paidi, Kalipada Pahan

PMC · DOI: 10.3390/cells13161374 · Cells · 2024-08-19

## Full-text entities

- **Genes:** PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}
- **Diseases:** Tay-Sachs Disease (MESH:D013661)
- **Chemicals:** Lipid (MESH:D008055), Gemfibrozil (MESH:D015248)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11353209/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11353209/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11353209/full.md

---
Source: https://tomesphere.com/paper/PMC11353209